Patents by Inventor Einav VAX

Einav VAX has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Frizzled receptor antibodies for treatment of cancer
    Patent number: 10465004
    Abstract: The invention provides antibodies or an antigen-binding portion thereof, which recognize the human Frizzled 7 receptor. Further, the invention provides methods of using these antibodies for the treatment cancer in a subject.
    Type: Grant
    Filed: January 1, 2015
    Date of Patent: November 5, 2019
    Assignees: Tel HaShomer Medical Research Infrastructure and Services Ltd., Ramot at Tel-Aviv University Ltd.
    Inventors: Benjamin Dekel, Naomi Pode-Shakked, Orit Harai-Steinberg, Michal Mark-Danieli, Einav Vax
  • FRIZZLED RECEPTOR ANTIBODIES FOR TREATMENT OF CANCER
    Publication number: 20160326245
    Abstract: The invention provides antibodies or an antigen-binding portion thereof, which recognize the human Frizzled 7 receptor. Further, the invention provides methods of using these antibodies for the treatment cancer in a subject.
    Type: Application
    Filed: January 1, 2015
    Publication date: November 10, 2016
    Inventors: Benjamin DEKEL, Naomi PODE-SHAKKED, Orit HARARI-STEINBERG, Michal MARK-DANIELI, Einav VAX